Eagle Asset Management Inc. Has $21.27 Million Stock Holdings in John Wiley & Sons, Inc. (NYSE:WLY)

Eagle Asset Management Inc. raised its position in John Wiley & Sons, Inc. (NYSE:WLY) by 40.1% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 407,997 shares of the company’s stock after buying an additional 116,772 shares during the period. Eagle Asset Management Inc.’s holdings in John Wiley & Sons were worth $21,273,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Intech Investment Management LLC bought a new position in John Wiley & Sons in the third quarter valued at about $543,000. Arjuna Capital lifted its position in John Wiley & Sons by 1.5% during the 3rd quarter. Arjuna Capital now owns 55,208 shares of the company’s stock valued at $2,664,000 after purchasing an additional 830 shares during the period. Victory Capital Management Inc. boosted its stake in shares of John Wiley & Sons by 113.6% in the 3rd quarter. Victory Capital Management Inc. now owns 35,762 shares of the company’s stock valued at $1,726,000 after purchasing an additional 19,017 shares during the last quarter. Atria Investments Inc boosted its stake in shares of John Wiley & Sons by 39.6% in the 3rd quarter. Atria Investments Inc now owns 13,509 shares of the company’s stock valued at $652,000 after purchasing an additional 3,833 shares during the last quarter. Finally, Verdence Capital Advisors LLC raised its stake in shares of John Wiley & Sons by 5.8% during the third quarter. Verdence Capital Advisors LLC now owns 7,617 shares of the company’s stock worth $368,000 after buying an additional 417 shares during the last quarter. 73.94% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at John Wiley & Sons

In related news, EVP Danielle Mcmahan sold 2,318 shares of the company’s stock in a transaction on Tuesday, October 8th. The shares were sold at an average price of $49.41, for a total value of $114,532.38. Following the completion of the sale, the executive vice president now owns 8,978 shares in the company, valued at $443,602.98. This represents a 20.52 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.62% of the company’s stock.

John Wiley & Sons Stock Up 2.4 %

Shares of NYSE WLY opened at $52.16 on Friday. John Wiley & Sons, Inc. has a fifty-two week low of $29.04 and a fifty-two week high of $53.79. The company has a debt-to-equity ratio of 1.27, a quick ratio of 0.53 and a current ratio of 0.57. The company’s 50 day simple moving average is $49.54 and its 200 day simple moving average is $44.95.

John Wiley & Sons (NYSE:WLY) last posted its quarterly earnings results on Thursday, September 5th. The company reported $0.47 earnings per share for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.08). John Wiley & Sons had a negative net margin of 6.00% and a positive return on equity of 21.59%. The company had revenue of $403.81 million during the quarter, compared to analyst estimates of $387.40 million. During the same period last year, the company earned $0.27 EPS. The business’s revenue for the quarter was down 10.5% compared to the same quarter last year.

John Wiley & Sons Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, October 24th. Shareholders of record on Tuesday, October 8th were issued a dividend of $0.352 per share. This represents a $1.41 dividend on an annualized basis and a yield of 2.70%. The ex-dividend date was Tuesday, October 8th. John Wiley & Sons’s dividend payout ratio (DPR) is currently -70.50%.

John Wiley & Sons Company Profile

John Wiley & Sons, Inc operates as a research and education company worldwide. The company operates through three segments: Research, Academic, and Talent. The company offers scientific, technical, medical, and scholarly journals, as well as related content and services to learned societies, individual researchers, other professionals, and academic, corporate, and government libraries.